0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Ketorolac Injection Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
Published Date: October 2022
|
Report Code: QYRE-Auto-24Z7589
Home | Market Reports | Health| Health Conditions| Pain Management
Global Ketorolac Injection Market Research Report 2022
BUY CHAPTERS

Global Ketorolac Injection Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Code: QYRE-Auto-24Z7589
Report
October 2022
Pages:116
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Ketorolac injection is used for the short-term treatment of moderate to severe pain. It is usually used before or after medical procedures or after surgery. Reducing pain helps you recover more comfortably so that you can return to your normal daily activities. This medication is a nonsteroidal anti-inflammatory drug.
Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Ketorolac Injection market is projected to reach US$ 1125.6 million by 2028 from an estimated US$ 959.9 million in 2022, at a CAGR of 2.7% during 2023 and 2028.

Global key ketorolac injection 核心厂商 Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma) etc. The top 2 companies hold a share about 20%. North America is the largest market, with a share about 40%, followed by Asia-Pacific and Europe with the share about 27% and 20%. In terms of product, 30mg/ml ketorolac injection is the largest segment, with a share over 64%. And in terms of application, the largest application is hospital, followed by clinics.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Ketorolac Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Ketorolac Injection.
The Ketorolac Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Ketorolac Injection market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ketorolac Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Pfizer
Fresenius Kabi
Fosun Pharma (Gland Pharma)
Sagent Pharmaceuticals
Hikma
Lunan Pharma
Alvogen
Chengdu Brilliant Pharmaceuticals
Athenex
Sichuan Medcalo
Julphar Bangladesh Ltd.
Yung Shin Pharm
Tianjin Chase Sun Pharmaceutical
ZISKA Pharmaceuticals
Product Type Insights
Global markets are presented by Ketorolac Injection concentration, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Ketorolac Injection are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by concentration, and during the historical period (2017-2022) and forecast period (2023-2028).
Ketorolac Injection Segment by Concentration
15mg/ml
30mg/ml
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Ketorolac Injection market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Ketorolac Injection market.

Ketorolac Injection Segment by Application

Hospital
Clinics
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Ketorolac Injection market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ketorolac Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Ketorolac Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Ketorolac Injection industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ketorolac Injection

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

1 Study Coverage
1.1 Ketorolac Injection Product Introduction
1.2 Market by Concentration
1.2.1 Global Ketorolac Injection Market Size Growth Rate by Concentration (2017 VS 2021 VS 2028)
1.2.2 15mg/ml
1.2.3 30mg/ml
1.3 Market by Application
1.3.1 Global Ketorolac Injection Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Ketorolac Injection Market Size Estimates and Forecasts
2.1.1 Global Ketorolac Injection Revenue 2017-2028
2.1.2 Global Ketorolac Injection Sales 2017-2028
2.2 Ketorolac Injection Market Size by Region: 2022 Versus 2028
2.3 Ketorolac Injection Sales by Region (2017-2028)
2.3.1 Global Ketorolac Injection Sales by Region: 2017-2022
2.3.2 Global Ketorolac Injection Sales Forecast by Region (2023-2028)
2.3.3 Global Ketorolac Injection Sales Market Share by Region (2017-2028)
2.4 Ketorolac Injection Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Ketorolac Injection Revenue by Region: 2017-2022
2.4.2 Global Ketorolac Injection Revenue Forecast by Region (2023-2028)
2.4.3 Global Ketorolac Injection Revenue Market Share by Region (2017-2028)
3 Global Ketorolac Injection by Manufacturers
3.1 Global Top Ketorolac Injection Manufacturers by Sales
3.1.1 Global Ketorolac Injection Sales by Manufacturer (2017-2022)
3.1.2 Global Ketorolac Injection Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Ketorolac Injection Manufacturers by Revenue
3.2.1 Global Ketorolac Injection Revenue by Manufacturer (2017-2022)
3.2.2 Global Ketorolac Injection Revenue Share by Manufacturer (2017-2022)
3.3 Global Ketorolac Injection Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Ketorolac Injection Manufacturers Covered: Ranking by Revenue
3.4.2 Global Ketorolac Injection Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Ketorolac Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Ketorolac Injection Manufacturing Base Distribution, Product Type
3.5.1 Ketorolac Injection Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Ketorolac Injection Product Type
3.5.3 Date of International Manufacturers Enter into Ketorolac Injection Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Pfizer
4.1.1 Pfizer Corporation Information
4.1.2 Pfizer Description, Business Overview
4.1.3 Pfizer Ketorolac Injection Products Offered
4.1.4 Pfizer Ketorolac Injection Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Pfizer Ketorolac Injection Sales by Product in 2021
4.1.6 Pfizer Ketorolac Injection Sales by Application in 2021
4.1.7 Pfizer Ketorolac Injection Sales by Geographic Area in 2021
4.1.8 Pfizer Recent Developments
4.2 Fresenius Kabi
4.2.1 Fresenius Kabi Corporation Information
4.2.2 Fresenius Kabi Description, Business Overview
4.2.3 Fresenius Kabi Ketorolac Injection Products Offered
4.2.4 Fresenius Kabi Ketorolac Injection Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Fresenius Kabi Ketorolac Injection Sales by Product in 2021
4.2.6 Fresenius Kabi Ketorolac Injection Sales by Application in 2021
4.2.7 Fresenius Kabi Ketorolac Injection Sales by Geographic Area in 2021
4.2.8 Fresenius Kabi Recent Developments
4.3 Fosun Pharma (Gland Pharma)
4.3.1 Fosun Pharma (Gland Pharma) Corporation Information
4.3.2 Fosun Pharma (Gland Pharma) Description, Business Overview
4.3.3 Fosun Pharma (Gland Pharma) Ketorolac Injection Products Offered
4.3.4 Fosun Pharma (Gland Pharma) Ketorolac Injection Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Fosun Pharma (Gland Pharma) Ketorolac Injection Sales by Product in 2021
4.3.6 Fosun Pharma (Gland Pharma) Ketorolac Injection Sales by Application in 2021
4.3.7 Fosun Pharma (Gland Pharma) Ketorolac Injection Sales by Geographic Area in 2021
4.3.8 Fosun Pharma (Gland Pharma) Recent Developments
4.4 Sagent Pharmaceuticals
4.4.1 Sagent Pharmaceuticals Corporation Information
4.4.2 Sagent Pharmaceuticals Description, Business Overview
4.4.3 Sagent Pharmaceuticals Ketorolac Injection Products Offered
4.4.4 Sagent Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Sagent Pharmaceuticals Ketorolac Injection Sales by Product in 2021
4.4.6 Sagent Pharmaceuticals Ketorolac Injection Sales by Application in 2021
4.4.7 Sagent Pharmaceuticals Ketorolac Injection Sales by Geographic Area in 2021
4.4.8 Sagent Pharmaceuticals Recent Developments
4.5 Hikma
4.5.1 Hikma Corporation Information
4.5.2 Hikma Description, Business Overview
4.5.3 Hikma Ketorolac Injection Products Offered
4.5.4 Hikma Ketorolac Injection Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Hikma Ketorolac Injection Sales by Product in 2021
4.5.6 Hikma Ketorolac Injection Sales by Application in 2021
4.5.7 Hikma Ketorolac Injection Sales by Geographic Area in 2021
4.5.8 Hikma Recent Developments
4.6 Lunan Pharma
4.6.1 Lunan Pharma Corporation Information
4.6.2 Lunan Pharma Description, Business Overview
4.6.3 Lunan Pharma Ketorolac Injection Products Offered
4.6.4 Lunan Pharma Ketorolac Injection Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Lunan Pharma Ketorolac Injection Sales by Product in 2021
4.6.6 Lunan Pharma Ketorolac Injection Sales by Application in 2021
4.6.7 Lunan Pharma Ketorolac Injection Sales by Geographic Area in 2021
4.6.8 Lunan Pharma Recent Development
4.7 Alvogen
4.7.1 Alvogen Corporation Information
4.7.2 Alvogen Description, Business Overview
4.7.3 Alvogen Ketorolac Injection Products Offered
4.7.4 Alvogen Ketorolac Injection Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Alvogen Ketorolac Injection Sales by Product in 2021
4.7.6 Alvogen Ketorolac Injection Sales by Application in 2021
4.7.7 Alvogen Ketorolac Injection Sales by Geographic Area in 2021
4.7.8 Alvogen Recent Development
4.8 Chengdu Brilliant Pharmaceuticals
4.8.1 Chengdu Brilliant Pharmaceuticals Corporation Information
4.8.2 Chengdu Brilliant Pharmaceuticals Description, Business Overview
4.8.3 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Products Offered
4.8.4 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales by Product in 2021
4.8.6 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales by Application in 2021
4.8.7 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales by Geographic Area in 2021
4.8.8 Chengdu Brilliant Pharmaceuticals Recent Development
4.9 Athenex
4.9.1 Athenex Corporation Information
4.9.2 Athenex Description, Business Overview
4.9.3 Athenex Ketorolac Injection Products Offered
4.9.4 Athenex Ketorolac Injection Sales, Revenue and Gross Margin (2017-2022)
4.9.5 Athenex Ketorolac Injection Sales by Product in 2021
4.9.6 Athenex Ketorolac Injection Sales by Application in 2021
4.9.7 Athenex Ketorolac Injection Sales by Geographic Area in 2021
4.9.8 Athenex Recent Development
4.10 Sichuan Medcalo
4.10.1 Sichuan Medcalo Corporation Information
4.10.2 Sichuan Medcalo Description, Business Overview
4.10.3 Sichuan Medcalo Ketorolac Injection Products Offered
4.10.4 Sichuan Medcalo Ketorolac Injection Sales, Revenue and Gross Margin (2017-2022)
4.10.5 Sichuan Medcalo Ketorolac Injection Sales by Product in 2021
4.10.6 Sichuan Medcalo Ketorolac Injection Sales by Application in 2021
4.10.7 Sichuan Medcalo Ketorolac Injection Sales by Geographic Area in 2021
4.10.8 Sichuan Medcalo Recent Development
4.11 Julphar Bangladesh Ltd.
4.11.1 Julphar Bangladesh Ltd. Corporation Information
4.11.2 Julphar Bangladesh Ltd. Description, Business Overview
4.11.3 Julphar Bangladesh Ltd. Ketorolac Injection Products Offered
4.11.4 Julphar Bangladesh Ltd. Ketorolac Injection Sales, Revenue and Gross Margin (2017-2022)
4.11.5 Julphar Bangladesh Ltd. Ketorolac Injection Sales by Product in 2021
4.11.6 Julphar Bangladesh Ltd. Ketorolac Injection Sales by Application in 2021
4.11.7 Julphar Bangladesh Ltd. Ketorolac Injection Sales by Geographic Area in 2021
4.11.8 Julphar Bangladesh Ltd. Recent Development
4.12 Yung Shin Pharm
4.12.1 Yung Shin Pharm Corporation Information
4.12.2 Yung Shin Pharm Description, Business Overview
4.12.3 Yung Shin Pharm Ketorolac Injection Products Offered
4.12.4 Yung Shin Pharm Ketorolac Injection Sales, Revenue and Gross Margin (2017-2022)
4.12.5 Yung Shin Pharm Ketorolac Injection Sales by Product in 2021
4.12.6 Yung Shin Pharm Ketorolac Injection Sales by Application in 2021
4.12.7 Yung Shin Pharm Ketorolac Injection Sales by Geographic Area in 2021
4.12.8 Yung Shin Pharm Recent Development
4.13 Tianjin Chase Sun Pharmaceutical
4.13.1 Tianjin Chase Sun Pharmaceutical Corporation Information
4.13.2 Tianjin Chase Sun Pharmaceutical Description, Business Overview
4.13.3 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Products Offered
4.13.4 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales, Revenue and Gross Margin (2017-2022)
4.13.5 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales by Product in 2021
4.13.6 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales by Application in 2021
4.13.7 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales by Geographic Area in 2021
4.13.8 Tianjin Chase Sun Pharmaceutical Recent Development
4.14 ZISKA Pharmaceuticals
4.14.1 ZISKA Pharmaceuticals Corporation Information
4.14.2 ZISKA Pharmaceuticals Description, Business Overview
4.14.3 ZISKA Pharmaceuticals Ketorolac Injection Products Offered
4.14.4 ZISKA Pharmaceuticals Ketorolac Injection Sales, Revenue and Gross Margin (2017-2022)
4.14.5 ZISKA Pharmaceuticals Ketorolac Injection Sales by Product in 2021
4.14.6 ZISKA Pharmaceuticals Ketorolac Injection Sales by Application in 2021
4.14.7 ZISKA Pharmaceuticals Ketorolac Injection Sales by Geographic Area in 2021
4.14.8 ZISKA Pharmaceuticals Recent Development
5 Breakdown Data by Concentration
5.1 Global Ketorolac Injection Sales by Concentration (2017-2028)
5.1.1 Global Ketorolac Injection Sales by Concentration (2017-2022)
5.1.2 Global Ketorolac Injection Sales Forecast by Concentration (2023-2028)
5.1.3 Global Ketorolac Injection Sales Market Share by Concentration (2017-2028)
5.2 Global Ketorolac Injection Revenue Forecast by Concentration (2017-2028)
5.2.1 Global Ketorolac Injection Revenue by Concentration (2017-2022)
5.2.2 Global Ketorolac Injection Revenue Forecast by Concentration (2023-2028)
5.2.3 Global Ketorolac Injection Revenue Market Share by Concentration (2017-2028)
5.3 Ketorolac Injection Average Selling Price (ASP) by Concentration (2017-2028)
6 Breakdown Data by Application
6.1 Global Ketorolac Injection Sales by Application (2017-2028)
6.1.1 Global Ketorolac Injection Sales by Application (2017-2022)
6.1.2 Global Ketorolac Injection Sales Forecast by Application (2023-2028)
6.1.3 Global Ketorolac Injection Sales Market Share by Application (2017-2028)
6.2 Global Ketorolac Injection Revenue Forecast by Application (2017-2028)
6.2.1 Global Ketorolac Injection Revenue by Application (2017-2022)
6.2.2 Global Ketorolac Injection Revenue Forecast by Application (2023-2028)
6.2.3 Global Ketorolac Injection Revenue Market Share by Application (2017-2028)
6.3 Ketorolac Injection Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Ketorolac Injection Market Size YoY Growth 2017-2028
7.2 North America Ketorolac Injection Market Facts & Figures by Country
7.2.1 North America Ketorolac Injection Sales by Country (2017-2028)
7.2.2 North America Ketorolac Injection Revenue by Country (2017-2028)
7.3 North America Ketorolac Injection Sales by Concentration
7.4 North America Ketorolac Injection Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Ketorolac Injection Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Ketorolac Injection Market Facts & Figures by Region
8.2.1 Asia-Pacific Ketorolac Injection Sales by Region (2017-2028)
8.2.2 Asia-Pacific Ketorolac Injection Revenue by Region (2017-2028)
8.3 Asia-Pacific Ketorolac Injection Sales by Concentration
8.4 Asia-Pacific Ketorolac Injection Sales by Application
9 Europe
9.1 Europe Ketorolac Injection Market Size YoY Growth 2017-2028
9.2 Europe Ketorolac Injection Market Facts & Figures by Country
9.2.1 Europe Ketorolac Injection Sales by Country (2017-2028)
9.2.2 Europe Ketorolac Injection Revenue by Country (2017-2028)
9.3 Europe Ketorolac Injection Sales by Concentration
9.4 Europe Ketorolac Injection Sales by Application
10 Latin America
10.1 Latin America Ketorolac Injection Market Size YoY Growth 2017-2028
10.2 Latin America Ketorolac Injection Market Facts & Figures by Country
10.2.1 Latin America Ketorolac Injection Sales by Country (2017-2028)
10.2.2 Latin America Ketorolac Injection Revenue by Country (2017-2028)
10.3 Latin America Ketorolac Injection Sales by Concentration
10.4 Latin America Ketorolac Injection Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Ketorolac Injection Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Ketorolac Injection Market Facts & Figures by Country
11.2.1 Middle East and Africa Ketorolac Injection Sales by Country (2017-2028)
11.2.2 Middle East and Africa Ketorolac Injection Revenue by Country (2017-2028)
11.3 Middle East and Africa Ketorolac Injection Sales by Concentration
11.4 Middle East and Africa Ketorolac Injection Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Ketorolac Injection Supply Chain Analysis
12.2 Ketorolac Injection Key Raw Materials and Upstream Suppliers
12.3 Ketorolac Injection Clients Analysis
12.4 Ketorolac Injection Sales Channel and Sales Model Analysis
12.4.1 Ketorolac Injection Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Ketorolac Injection Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Ketorolac Injection Distributors
13 Market Dynamics
13.1 Ketorolac Injection Industry Trends
13.2 Ketorolac Injection Market Drivers
13.3 Ketorolac Injection Market Challenges
13.4 Ketorolac Injection Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Ketorolac Injection Market Size Growth Rate by Concentration (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Major Manufacturers of 15mg/ml
    Table 3. Major Manufacturers of 30mg/ml
    Table 4. Global Ketorolac Injection Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Ketorolac Injection Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
    Table 6. Global Ketorolac Injection Sales by Region (2017-2022) & (K Units)
    Table 7. Global Ketorolac Injection Sales Forecast by Region (2023-2028) & (K Units)
    Table 8. Global Ketorolac Injection Revenue by Region (2017-2022) & (US$ Million)
    Table 9. Global Ketorolac Injection Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 10. Global Ketorolac Injection Sales by Manufacturer (2017-2022) & (K Units)
    Table 11. Global Ketorolac Injection Sales Share by Manufacturer (2017-2022)
    Table 12. Ketorolac Injection Revenue by Manufacturer (2017-2022) & (US$ Million)
    Table 13. Ketorolac Injection Revenue Share by Manufacturer (2017-2022)
    Table 14. Key Manufacturers Ketorolac Injection Price (2017-2022) & (US$/K Units)
    Table 15. Ranking of Global Top Ketorolac Injection Manufacturers by Revenue (US$ Million) in 2021
    Table 16. Global Ketorolac Injection Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
    Table 17. Global Ketorolac Injection by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ketorolac Injection as of 2021)
    Table 18. Ketorolac Injection Manufacturers Manufacturing Base Distribution and Headquarters
    Table 19. Manufacturers Ketorolac Injection Product Type
    Table 20. Date of International Manufacturers Enter into Ketorolac Injection Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Pfizer Corporation Information
    Table 23. Pfizer Description and Business Overview
    Table 24. Pfizer Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
    Table 25. Pfizer Ketorolac Injection Product
    Table 26. Pfizer Ketorolac Injection Sales Proportion of Ketorolac Injection by Product in 2021
    Table 27. Pfizer Ketorolac Injection Sales Proportion of Ketorolac Injection by Application in 2021
    Table 28. Pfizer Ketorolac Injection Sales Proportion of Ketorolac Injection by Geographic Area in 2021
    Table 29. Pfizer Recent Development
    Table 30. Fresenius Kabi Corporation Information
    Table 31. Fresenius Kabi Description and Business Overview
    Table 32. Fresenius Kabi Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
    Table 33. Fresenius Kabi Ketorolac Injection Product
    Table 34. Fresenius Kabi Ketorolac Injection Sales Proportion of Ketorolac Injection by Product in 2021
    Table 35. Fresenius Kabi Ketorolac Injection Sales Proportion of Ketorolac Injection by Application in 2021
    Table 36. Fresenius Kabi Ketorolac Injection Sales Proportion of Ketorolac Injection by Geographic Area in 2021
    Table 37. Fresenius Kabi Recent Development
    Table 38. Fosun Pharma (Gland Pharma) Corporation Information
    Table 39. Fosun Pharma (Gland Pharma) Description and Business Overview
    Table 40. Fosun Pharma (Gland Pharma) Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
    Table 41. Fosun Pharma (Gland Pharma) Ketorolac Injection Product
    Table 42. Fosun Pharma (Gland Pharma) Ketorolac Injection Sales Proportion of Ketorolac Injection by Product in 2021
    Table 43. Fosun Pharma (Gland Pharma) Ketorolac Injection Sales Proportion of Ketorolac Injection by Application in 2021
    Table 44. Fosun Pharma (Gland Pharma) Ketorolac Injection Sales Proportion of Ketorolac Injection by Geographic Area in 2021
    Table 45. Fosun Pharma (Gland Pharma) Recent Development
    Table 46. Sagent Pharmaceuticals Corporation Information
    Table 47. Sagent Pharmaceuticals Description and Business Overview
    Table 48. Sagent Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
    Table 49. Sagent Pharmaceuticals Ketorolac Injection Product
    Table 50. Sagent Pharmaceuticals Ketorolac Injection Sales Proportion of Ketorolac Injection by Product in 2021
    Table 51. Sagent Pharmaceuticals Ketorolac Injection Sales Proportion of Ketorolac Injection by Application in 2021
    Table 52. Sagent Pharmaceuticals Ketorolac Injection Sales Proportion of Ketorolac Injection by Geographic Area in 2021
    Table 53. Sagent Pharmaceuticals Recent Development
    Table 54. Hikma Corporation Information
    Table 55. Hikma Description and Business Overview
    Table 56. Hikma Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
    Table 57. Hikma Ketorolac Injection Product
    Table 58. Hikma Ketorolac Injection Sales Proportion of Ketorolac Injection by Product in 2021
    Table 59. Hikma Ketorolac Injection Sales Proportion of Ketorolac Injection by Application in 2021
    Table 60. Hikma Ketorolac Injection Sales Proportion of Ketorolac Injection by Geographic Area in 2021
    Table 61. Hikma Recent Development
    Table 62. Lunan Pharma Corporation Information
    Table 63. Lunan Pharma Description and Business Overview
    Table 64. Lunan Pharma Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
    Table 65. Lunan Pharma Ketorolac Injection Product
    Table 66. Lunan Pharma Ketorolac Injection Sales Proportion of Ketorolac Injection by Product in 2021
    Table 67. Lunan Pharma Ketorolac Injection Sales Proportion of Ketorolac Injection by Application in 2021
    Table 68. Lunan Pharma Ketorolac Injection Sales Proportion of Ketorolac Injection by Geographic Area in 2021
    Table 69. Alvogen Corporation Information
    Table 70. Alvogen Description and Business Overview
    Table 71. Alvogen Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
    Table 72. Alvogen Ketorolac Injection Product
    Table 73. Alvogen Ketorolac Injection Sales Proportion of Ketorolac Injection by Product in 2021
    Table 74. Alvogen Ketorolac Injection Sales Proportion of Ketorolac Injection by Application in 2021
    Table 75. Alvogen Ketorolac Injection Sales Proportion of Ketorolac Injection by Geographic Area in 2021
    Table 76. Chengdu Brilliant Pharmaceuticals Corporation Information
    Table 77. Chengdu Brilliant Pharmaceuticals Description and Business Overview
    Table 78. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
    Table 79. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product
    Table 80. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales Proportion of Ketorolac Injection by Product in 2021
    Table 81. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales Proportion of Ketorolac Injection by Application in 2021
    Table 82. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales Proportion of Ketorolac Injection by Geographic Area in 2021
    Table 83. Athenex Corporation Information
    Table 84. Athenex Description and Business Overview
    Table 85. Athenex Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
    Table 86. Athenex Ketorolac Injection Product
    Table 87. Athenex Ketorolac Injection Sales Proportion of Ketorolac Injection by Product in 2021
    Table 88. Athenex Ketorolac Injection Sales Proportion of Ketorolac Injection by Application in 2021
    Table 89. Athenex Ketorolac Injection Sales Proportion of Ketorolac Injection by Geographic Area in 2021
    Table 90. Sichuan Medcalo Corporation Information
    Table 91. Sichuan Medcalo Description and Business Overview
    Table 92. Sichuan Medcalo Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
    Table 93. Sichuan Medcalo Ketorolac Injection Product
    Table 94. Sichuan Medcalo Ketorolac Injection Sales Proportion of Ketorolac Injection by Product in 2021
    Table 95. Sichuan Medcalo Ketorolac Injection Sales Proportion of Ketorolac Injection by Application in 2021
    Table 96. Sichuan Medcalo Ketorolac Injection Sales Proportion of Ketorolac Injection by Geographic Area in 2021
    Table 97. Julphar Bangladesh Ltd. Corporation Information
    Table 98. Julphar Bangladesh Ltd. Description and Business Overview
    Table 99. Julphar Bangladesh Ltd. Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
    Table 100. Julphar Bangladesh Ltd. Ketorolac Injection Product
    Table 101. Julphar Bangladesh Ltd. Ketorolac Injection Sales Proportion of Ketorolac Injection by Product in 2021
    Table 102. Julphar Bangladesh Ltd. Ketorolac Injection Sales Proportion of Ketorolac Injection by Application in 2021
    Table 103. Julphar Bangladesh Ltd. Ketorolac Injection Sales Proportion of Ketorolac Injection by Geographic Area in 2021
    Table 104. Yung Shin Pharm Corporation Information
    Table 105. Yung Shin Pharm Description and Business Overview
    Table 106. Yung Shin Pharm Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
    Table 107. Yung Shin Pharm Ketorolac Injection Product
    Table 108. Yung Shin Pharm Ketorolac Injection Sales Proportion of Ketorolac Injection by Product in 2021
    Table 109. Yung Shin Pharm Ketorolac Injection Sales Proportion of Ketorolac Injection by Application in 2021
    Table 110. Yung Shin Pharm Ketorolac Injection Sales Proportion of Ketorolac Injection by Geographic Area in 2021
    Table 111. Tianjin Chase Sun Pharmaceutical Corporation Information
    Table 112. Tianjin Chase Sun Pharmaceutical Description and Business Overview
    Table 113. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
    Table 114. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product
    Table 115. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales Proportion of Ketorolac Injection by Product in 2021
    Table 116. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales Proportion of Ketorolac Injection by Application in 2021
    Table 117. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales Proportion of Ketorolac Injection by Geographic Area in 2021
    Table 118. ZISKA Pharmaceuticals Corporation Information
    Table 119. ZISKA Pharmaceuticals Description and Business Overview
    Table 120. ZISKA Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
    Table 121. ZISKA Pharmaceuticals Ketorolac Injection Product
    Table 122. ZISKA Pharmaceuticals Ketorolac Injection Sales Proportion of Ketorolac Injection by Product in 2021
    Table 123. ZISKA Pharmaceuticals Ketorolac Injection Sales Proportion of Ketorolac Injection by Application in 2021
    Table 124. ZISKA Pharmaceuticals Ketorolac Injection Sales Proportion of Ketorolac Injection by Geographic Area in 2021
    Table 125. Global Ketorolac Injection Sales by Concentration (2017-2022) & (K Units)
    Table 126. Global Ketorolac Injection Sales Forecast by Concentration (2023-2028) & (K Units)
    Table 127. Global Ketorolac Injection Revenue by Concentration (2017-2022) & (US$ Million)
    Table 128. Global Ketorolac Injection Revenue Forecast by Concentration (2023-2028) & (US$ Million)
    Table 129. Global Ketorolac Injection Sales by Application (2017-2022) & (K Units)
    Table 130. Global Ketorolac Injection Sales Forecast by Application (2023-2028) & (K Units)
    Table 131. Global Ketorolac Injection Revenue by Application (2017-2022) & (US$ Million)
    Table 132. Global Ketorolac Injection Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 133. North America Ketorolac Injection Sales by Country (2017-2022) & (K Units)
    Table 134. North America Ketorolac Injection Sales by Country (2023-2028) & (K Units)
    Table 135. North America Ketorolac Injection Revenue by Country (2017-2022) & (US$ Million)
    Table 136. North America Ketorolac Injection Revenue by Country (2023-2028) & (US$ Million)
    Table 137. North America Ketorolac Injection Sales by Concentration (2017-2022) & (K Units)
    Table 138. North America Ketorolac Injection Sales by Application (2017-2022) & (K Units)
    Table 139. Asia-Pacific Ketorolac Injection Sales by Region (2017-2022) & (K Units)
    Table 140. Asia-Pacific Ketorolac Injection Sales by Region (2023-2028) & (K Units)
    Table 141. Asia-Pacific Ketorolac Injection Revenue by Region (2017-2028) & (US$ Million)
    Table 142. Asia-Pacific Ketorolac Injection Revenue by Region (2023-2028) & (US$ Million)
    Table 143. Asia-Pacific Ketorolac Injection Sales by Concentration (2017-2022) & (K Units)
    Table 144. Asia-Pacific Ketorolac Injection Sales by Application (2017-2022) & (K Units)
    Table 145. Europe Ketorolac Injection Sales by Country (2017-2022) & (K Units)
    Table 146. Europe Ketorolac Injection Sales by Country (2023-2028) & (K Units)
    Table 147. Europe Ketorolac Injection Revenue by Country (2017-2022) & (US$ Million)
    Table 148. Europe Ketorolac Injection Revenue by Country (2023-2028) & (US$ Million)
    Table 149. Europe Ketorolac Injection Sales by Concentration (2017-2022) & (K Units)
    Table 150. Europe Ketorolac Injection Sales by Application (2017-2022) & (K Units)
    Table 151. Latin America Ketorolac Injection Sales by Country (2017-2022) & (K Units)
    Table 152. Latin America Ketorolac Injection Sales by Country (2023-2028) & (K Units)
    Table 153. Latin America Ketorolac Injection Revenue by Country (2017-2022) & (US$ Million)
    Table 154. Latin America Ketorolac Injection Revenue by Country (2023-2028) & (US$ Million)
    Table 155. Latin America Ketorolac Injection Sales by Concentration (2017-2022) & (K Units)
    Table 156. Latin America Ketorolac Injection Sales by Application (2017-2022) & (K Units)
    Table 157. Middle East and Africa Ketorolac Injection Sales by Country (2017-2022) & (K Units)
    Table 158. Middle East and Africa Ketorolac Injection Sales by Country (2023-2028) & (K Units)
    Table 159. Middle East and Africa Ketorolac Injection Revenue by Country (2017-2022) & (US$ Million)
    Table 160. Middle East and Africa Ketorolac Injection Revenue by Country (2023-2028) & (US$ Million)
    Table 161. Middle East and Africa Ketorolac Injection Sales by Concentration (2017-2022) & (K Units)
    Table 162. Middle East and Africa Ketorolac Injection Sales by Application (2017-2022) & (K Units)
    Table 163. Ketorolac Injection Key Raw Materials, Industry Status and Trend
    Table 164. Ketorolac Injection Key Raw Materials and Upstream Suppliers
    Table 165. Ketorolac Injection Clients Status and Trend
    Table 166. Ketorolac Injection Typical Clients
    Table 167. Ketorolac Injection Distributors
    Table 168. Ketorolac Injection Market Trends
    Table 169. Ketorolac Injection Market Drivers
    Table 170. Ketorolac Injection Market Challenges
    Table 171. Ketorolac Injection Market Restraints
    Table 172. Research Programs/Design for This Report
    Table 173. Key Data Information from Secondary Sources
    Table 174. Key Data Information from Primary Sources
List of Figures
    Figure 1. Ketorolac Injection Product Picture
    Figure 2. Global Ketorolac Injection Sales Market Share by Concentration in 2021 & 2028
    Figure 3. 15mg/ml Product Picture
    Figure 4. 30mg/ml Product Picture
    Figure 5. Global Ketorolac Injection Sales Market Share by Application in 2021 & 2028
    Figure 6. Hospital Examples
    Figure 7. Clinics Examples
    Figure 8. Others Examples
    Figure 9. Ketorolac Injection Report Years Considered
    Figure 10. Global Ketorolac Injection Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Ketorolac Injection Market Size 2017-2028 (US$ Million)
    Figure 12. Global Ketorolac Injection Sales 2017-2028 (K Units)
    Figure 13. Global Ketorolac Injection Market Size Market Share by Region: 2022 Versus 2028
    Figure 14. Global Ketorolac Injection Sales Market Share Forecast by Region (2017-2028)
    Figure 15. Global Ketorolac Injection Revenue Market Share by Region (2017-2028)
    Figure 16. Global Ketorolac Injection Sales Share by Manufacturer in 2021
    Figure 17. Ketorolac Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 18. Global Ketorolac Injection Sales Market Share Forecast by Concentration (2017-2028)
    Figure 19. Global Ketorolac Injection Revenue Market Share Forecast by Concentration (2017-2028)
    Figure 20. Ketorolac Injection Average Selling Price (ASP) by Concentration (2017-2022) & (US$/K Units)
    Figure 21. Global Ketorolac Injection Sales Market Share Forecast by Application (2017-2028)
    Figure 22. Global Ketorolac Injection Revenue Market Share Forecast by Application (2017-2028)
    Figure 23. Ketorolac Injection Average Selling Price (ASP) by Application (2017-2022) & (US$/K Units)
    Figure 24. North America Ketorolac Injection Revenue 2017-2028 (US$ Million)
    Figure 25. North America Ketorolac Injection Sales Market Share by Concentration (2017-2022)
    Figure 26. North America Ketorolac Injection Sales Market Share by Application (2017-2022)
    Figure 27. Asia-Pacific Ketorolac Injection Revenue 2017-2028 (US$ Million)
    Figure 28. Asia-Pacific Ketorolac Injection Sales Market Share by Region (2017-2028)
    Figure 29. Asia-Pacific Ketorolac Injection Revenue Market Share by Region (2017-2028)
    Figure 30. Asia-Pacific Ketorolac Injection Sales Market Share by Concentration (2017-2022)
    Figure 31. Asia-Pacific Ketorolac Injection Sales Market Share by Application (2017-2022)
    Figure 32. Europe Ketorolac Injection Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 33. Europe Ketorolac Injection Sales Market Share by Country (2017-2028)
    Figure 34. Europe Ketorolac Injection Revenue Market Share by Country (2017-2028)
    Figure 35. Europe Ketorolac Injection Sales Market Share by Concentration (2017-2022)
    Figure 36. Europe Ketorolac Injection Sales Market Share by Application (2017-2022)
    Figure 37. Latin America Ketorolac Injection Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 38. Latin America Ketorolac Injection Sales Market Share by Country (2017-2028)
    Figure 39. Latin America Ketorolac Injection Revenue Market Share by Country (2017-2022)
    Figure 40. Latin America Ketorolac Injection Sales Market Share by Concentration (2017-2022)
    Figure 41. Latin America Ketorolac Injection Sales Market Share by Application (2017-2022)
    Figure 42. Middle East and Africa Ketorolac Injection Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 43. Middle East and Africa Ketorolac Injection Sales Market Share by Country (2017-2028)
    Figure 44. Middle East and Africa Ketorolac Injection Revenue Market Share by Country (2017-2028)
    Figure 45. Middle East and Africa Ketorolac Injection Sales Market Share by Concentration (2017-2022)
    Figure 46. Middle East and Africa Ketorolac Injection Sales Market Share by Application (2017-2022)
    Figure 47. Ketorolac Injection Supply Chain (Upstream and Downstream Market)
    Figure 48. Global Production Market Share of Ketorolac Injection Raw Materials by Region in 2021
    Figure 49. Ketorolac Injection Distribution Channels
    Figure 50. Global Ketorolac Injection Percentage 2017-2028: Indirect Sales VS Direct Sales
    Figure 51. Global Ketorolac Injection Percentage 2017-2028: Online Sales VS Offline Sales
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS